Congenital Myasthenic Syndrome clinical trials

Explore recruiting congenital myasthenic syndrome clinical trials.

Recruiting congenital myasthenic syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Congenital Myasthenic Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1b study to investigate safety and tolerability of ARGX-119 in adult participants with DOK7 Congenital Myasthenic Syndrome (CMS)

Spain, Austria, Italy, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Congenital Myasthenic Syndrome trials by city

Congenital Myasthenic Syndrome in Toronto Congenital Myasthenic Syndrome in Vancouver Congenital Myasthenic Syndrome in Montreal Congenital Myasthenic Syndrome in Calgary Congenital Myasthenic Syndrome in Edmonton Congenital Myasthenic Syndrome in Ottawa Congenital Myasthenic Syndrome in Winnipeg Congenital Myasthenic Syndrome in Quebec City Congenital Myasthenic Syndrome in Hamilton Congenital Myasthenic Syndrome in Kitchener Congenital Myasthenic Syndrome in London Congenital Myasthenic Syndrome in Halifax Congenital Myasthenic Syndrome in New York Congenital Myasthenic Syndrome in Los Angeles Congenital Myasthenic Syndrome in Chicago Congenital Myasthenic Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease